Ovary Serous Adenocarcinoma disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

MCID: OVR062 MIFTS: 34	Ovary Serous Adenocarcinoma Categories: Cancer diseases, Endocrine diseases, Reproductive diseases
Genes Variations Tissues Related diseases Publications Pathways Drugs Download Expand all tables

Sources

Aliases & Classifications for Ovary Serous Adenocarcinoma

MalaCards integrated aliases for Ovary Serous Adenocarcinoma:

Name: Ovary Serous Adenocarcinoma ¹² ¹⁵

Malignant Ovarian Serous Tumor ¹² ⁷³

Serous Carcinoma of Ovary ¹²

Classifications:

MalaCards categories:
Global: Cancer diseases
Anatomical: Endocrine diseases Reproductive diseases

See all MalaCards categories (disease lists)

External Ids:

Disease Ontology ¹² DOID:5744

NCIt ⁵⁰ C40025 C7550

UMLS ⁷³ C1335177 C1518234

Sources

Summaries for Ovary Serous Adenocarcinoma

Disease Ontology : ¹² An ovary adenocarcinoma that derives from the lining of a cavity that produces a serum-like fluid (a serous cavity).

MalaCards based summary : Ovary Serous Adenocarcinoma, also known as malignant ovarian serous tumor, is related to ovarian serous cystadenocarcinoma and schimmelpenning-feuerstein-mims syndrome. An important gene associated with Ovary Serous Adenocarcinoma is HTRA3 (HtrA Serine Peptidase 3), and among its related pathways/superpathways are Cell surface interactions at the vascular wall and C-type lectin receptor signaling pathway. The drugs Gemcitabine and Doxorubicin have been mentioned in the context of this disorder. Affiliated tissues include ovary and t cells.

Sources

Related Diseases for Ovary Serous Adenocarcinoma

Diseases related to Ovary Serous Adenocarcinoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 56)

#	Related Disease	Score	Top Affiliating Genes
1	ovarian serous cystadenocarcinoma	31.1	HRAS UBE4A USP2 ZNF217
2	schimmelpenning-feuerstein-mims syndrome	10.6	HRAS KRAS
3	periampullary adenoma	10.6	HRAS KRAS
4	paronychia	10.6	HRAS KRAS
5	bile duct cysts	10.6	HRAS KRAS
6	secondary hypertrophic osteoarthropathy	10.6	HRAS KRAS
7	nasal cavity adenocarcinoma	10.6	HRAS KRAS
8	anal canal adenocarcinoma	10.6	HRAS KRAS
9	ampulla of vater neoplasm	10.5	HRAS KRAS
10	lung adenoid cystic carcinoma	10.5	HRAS KRAS
11	nevus, epidermal	10.5	HRAS KRAS
12	villous adenoma	10.5	GNAS KRAS
13	acneiform dermatitis	10.5	HRAS KRAS
14	colloid carcinoma of the pancreas	10.5	HRAS KRAS
15	appendix cancer	10.5	GNAS KRAS
16	mixed cell type cancer	10.5	HRAS KRAS
17	adenosquamous cell lung carcinoma	10.4	HRAS KRAS
18	adenosquamous pancreas carcinoma	10.4	HRAS KRAS
19	core binding factor acute myeloid leukemia	10.4	HRAS KRAS
20	colonic benign neoplasm	10.4	CEACAM5 KRAS
21	biliary tract neoplasm	10.4	HRAS KRAS
22	duodenum cancer	10.3	HRAS KRAS
23	liver angiosarcoma	10.3	HRAS KRAS
24	pancreatic cystadenocarcinoma	10.3	CEACAM5 KRAS
25	lacrimal gland adenocarcinoma	10.3	HRAS KRAS
26	prostate squamous cell carcinoma	10.2	CEACAM5 HRAS
27	cecum adenocarcinoma	10.1	HRAS KRAS
28	sigmoid neoplasm	10.1	CEACAM5 HRAS KRAS
29	apocrine adenoma	10.1	CEACAM5 HRAS KRAS
30	aggressive digital papillary adenocarcinoma	10.0	CEACAM5 HRAS KRAS
31	biliary papillomatosis	10.0	CEACAM5 HRAS KRAS
32	bile duct adenocarcinoma	10.0	CEACAM5 HRAS KRAS
33	gastrointestinal system benign neoplasm	10.0	CEACAM5 HRAS KRAS
34	intestinal benign neoplasm	10.0	CEACAM5 HRAS KRAS
35	ovarian cancer 1	10.0	CEACAM5 HRAS KRAS
36	ovary epithelial cancer	10.0	CEACAM5 HRAS KRAS
37	colorectal adenocarcinoma	10.0	CEACAM5 HRAS KRAS
38	pulmonic stenosis	10.0	HRAS KRAS
39	female reproductive organ cancer	10.0	CEACAM5 HRAS KRAS
40	respiratory system cancer	10.0	CEACAM5 HRAS KRAS
41	rectal neoplasm	10.0	CEACAM5 HRAS KRAS
42	cell type cancer	10.0	CEACAM5 HRAS KRAS
43	gastrointestinal system cancer	10.0	CEACAM5 HRAS KRAS
44	pancreatic mucinous cystadenoma	10.0	CEACAM5 HRAS
45	endometrial stromal nodule	9.8
46	choriocarcinoma	9.8
47	costello syndrome	9.8	HRAS KRAS
48	ovary adenocarcinoma	9.7	CEACAM5 HRAS KRAS ZNF217
49	malignant ovarian surface epithelial-stromal neoplasm	9.6	CEACAM5 HRAS KRAS ZNF217
50	cell type benign neoplasm	9.6	CEACAM5 GNAS HRAS KRAS

Graphical network of the top 20 diseases related to Ovary Serous Adenocarcinoma:

Sources

Symptoms & Phenotypes for Ovary Serous Adenocarcinoma

Sources

Drugs & Therapeutics for Ovary Serous Adenocarcinoma

Drugs for Ovary Serous Adenocarcinoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 27)

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

Gemcitabine

Approved

Phase 2

95058-81-4

60750

Synonyms:

103882-84-4

122111-03-9

2',2'-DFDC

2',2'-DiF-dC

2',2'-difluoro-2'-Deoxycytidine

2',2'-Difluoro-2'-deoxycytidine

2',2'-Difluorodeoxycytidine

2'-Deoxy-.beta.-D-2',2'-difluorocytidine

2'-Deoxy-2',2'-difluorocytidine

2'-Deoxy-2',2''-difluorocytidine-5'-O-monophosphate

2'-Deoxy-2'-difluorocytidine

4-amino-1-((2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one

4-amino-1-((2R,4R,5R)-3,3-difluoro-4-Hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one

4-amino-1-((2R,4R,5R)-3,3-Difluoro-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidin-2(1H)-one

4-Amino-1-[(2R,4R,5R)-3,3-difluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one

4-Amino-1-[3,3-difluoro-4-hydroxy-5-(hydroxymethyl) tetrahydrofuran-2-yl]-1H-pyrimidin-2-one

95058-81-4

AB1004842

AC1L1TUQ

C07650

CCRIS 8984

CHEBI:175901

CHEMBL888

CID60750

Cytidine, 2'-deoxy-2',2'-difluoro-2'-Deoxy-.beta.-D-2',2'-difluorocytidine

D02368

DB00441

DDFC

DFdC

DFDC

DFdCyd

Folfugem

Gamcitabine

Gemcel

Gemcin

Gemcitabin

Gemcitabina

Gemcitabina [INN-Spanish]

gemcitabine

Gemcitabine

Gemcitabine (USAN/INN)

Gemcitabine HCl

Gemcitabine hydrochloride

Gemcitabine stereoisomer

Gemcitabine, (alpha-D-threo-pentofuranosyl)-isomer

Gemcitabine, (beta-D-threo-pentafuranosyl)-isomer

Gemcitabine, (D-threo-pentafuranosyl)-isomer

Gemcitabinum

Gemcitabinum [INN-Latin]

GemLip

Gemtro

Gemzar

Gemzar (hydrochloride)

GEO

HMS2089P10

HSDB 7567

Inno-D07001

LS-59139

LY 188011

LY188011

LY-188011

NCGC00168784-01

NChemBio.2007.10-comp25

nchembio.573-comp7

nchembio.90-comp2

NSC 613327

NSC613327

TL8005979

UNII-B76N6SBZ8R

Zefei

ZINC18279854

Doxorubicin

Approved, Investigational

Phase 2

23214-92-8

31703

Synonyms:

(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranoside

(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside

(1S,3S)-3-Glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside

(8S-cis)-10-((3-amino-2,3,6-Trideoxy-a-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione

(8S-cis)-10-((3-amino-2,3,6-Trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione

(8S-cis)-10-((3-amino-2,3,6-Trideoxy-α-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione

111266-55-8

14-hydroxydaunomycin

14-Hydroxydaunomycin

14-hydroxydaunorubicine

14-Hydroxydaunorubicine

23214-92-8

23257-17-2

24385-08-8

25311-50-6

25316-40-9

25316-40-9 (hydrochloride)

29042-30-6

AC1L1M5T

AC1Q29OJ

adiblastine (hydrochloride salt)

ADM

ADR

adr iablatina (hydrochloride salt)

Adriablastin

Adriablastine

adriablastine (hydrochloride salt)

adriablatina (hydrochloride salt)

Adriacin (hydrochloride salt)

Adriamycin

Adriamycin PFS

Adriamycin PFS (hydrochloride salt)

Adriamycin RDF

Adriamycin RDF (hydrochloride salt)

Adriamycin semiquinone

Adriamycin Semiquinone

Adriblas tina

Adriblastin

Adriblastina

Adriblastina (hydrochloride salt)

Adriblastina (TN)

Adriblastine

adriblatina (hydrochloride salt)

Adrimedac

Aerosolized Doxorubicin

Baxter brand OF doxorubicin hydrochloride

Bedford brand OF doxorubicin hydrochloride

BPBio1_000502

BRD-K92093830-003-04-3

Bristol-myers squibb brand OF doxorubicin hydrochloride

BSPBio_000456

BSPBio_001031

C01661

C27H29NO11

Caelyx

CCRIS 739

Cell pharm brand OF doxorubicin hydrochloride

CHEBI:28748

CHEMBL179

CID31703

Columbia brand OF doxorubicin hydrochloride

Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74

Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120

D03899

DB00997

DM2

Doxil

Doxo

doxo Cell

doxo-Cell

Doxolem

doxorubicin

Doxorubicin

Doxorubicin (USAN/INN)

Doxorubicin [USAN:INN:BAN]

Doxorubicin citrate

Doxorubicin HCl

Doxorubicin hexal

Doxorubicin hydrochloride

Doxorubicin Hydrochloride

Doxorubicin hydrochloride (hydrochloride salt)

Doxorubicin NC

Doxorubicina

Doxorubicina [INN-Spanish]

Doxorubicina ferrer farm

Doxorubicina funk

Doxorubicina tedec

Doxorubicine

Doxorubicine [INN-French]

Doxorubicine baxter

Doxorubicin-hLL1

Doxorubicin-hLL1 conjugate

Doxorubicin-P4/D10

Doxorubicin-P4/D10 conjugate

Doxorubicinum

Doxorubicinum [INN-Latin]

Doxotec

DOX-SL

EINECS 245-495-6

Elan brand OF doxorubicin hydrochloride

Farmablastina (hydrochloride salt)

Farmiblastina

Ferrer brand OF doxorubicin hydrochloride

FI 106

Hexal brand OF doxorubicin hydrochloride

HMS2089H06

HSDB 3070

Hydrochloride, doxorubicin

Hydroxydaunomycin hydrochlor ide (hydrochloride salt)

Hydroxydaunomycin hydrochloride (hydrochloride salt)

Hydroxydaunorubicin

Hydroxydaunorubicin hydrochloride (hydrochloride salt)

JT9100000

Kenfarma brand OF doxorubicin hydrochloride

Lemery brand OF doxorubicin hydrochloride

LMPK13050001

LS-1029

LS-165655

Medac brand OF doxorubicin hydrochloride

MLS000759533

Myocet

NChemBio.2007.10-comp13

nchembio809-comp5

NCI-C01514

NDC 38242-874

Neocorp brand OF doxorubicin hydrochloride

NIOSH/JT9100000

NSC 123127

Onkodox

Onkoworks brand OF doxorubicin hydrochloride

Pfizer brand OF doxorubicin hydrochloride

Prasfarma brand OF doxorubicin hydrochloride

Prestwick0_000438

Prestwick1_000438

Prestwick2_000438

Prestwick3_000438

Probes1_000151

Probes2_000129

RDF Rubex

Resmycin

Ribodoxo

Ribosepharm brand OF doxorubicin hydrochloride

Rubex

Rubex (hydrochloride salt)

SMP1_000106

SPBio_002395

Tedec meiji brand OF doxorubicin hydrochloride

ThermoDox

TLC D-99

Triferric doxorubicin

UNII-80168379AG

Urokit doxo cell

Urokit doxo-cell

Topotecan

Approved, Investigational

Phase 2

119413-54-6, 123948-87-8

60700

Synonyms:

(4S)-10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione

(S)-10-((Dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione

(S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione

(S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]-quinoline-3,14(4H,12H)-dione

(S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE

123948-87-8

9 Dimethylaminomethyl 10 hydroxycamptothecin

9-[(dimethylamino)Methyl]-10-hydroxy-(4S)-camptothecin

9-Dimethylaminomethyl-10-hydroxycamptothecin

AC-11592

AC1L1TQZ

AC1Q6APZ

BSPBio_002348

C11158

C23H23N3O5

CCRIS 8163

CHEBI:107501

CHEBI:46035

CHEMBL84

CID60700

D08618

DB01030

HMS2090B20

HSCI1_000228

Hycamptamine

Hycamptin

Hycamtamine

Hycamtin

Hycamtin (TN)

Hydrochloride, nogitecan

Hydrochloride, topotecan

LS-127395

MLS000759456

NCGC00178695-01

NChemBio.2007.10-comp24

NCI60_004771

NCIStruc1_001659

NCIStruc2_001796

Nogitecan hydrochloride

NSC609699

SK And F 104864 a

SK And F104864a

SK And F-104864-a

SK&F-104864-A

SKF 104864

SKF-104864-A

SKF-S 104864

SmithKline beecham brand OF topotecan hydrochloride

SMP2_000312

SMP2_000327

SMR000466344

TOPO

topotecan

Topotecan (BAN)

Topotecan [INN:BAN]

Topotecan Hcl

Topotecan hydrochloride

Topotecan Hydrochloride

Topotecan lactone

Topotecan Lactone

Topotecan monohydrochloride, (S)-isomer

Topotecan Monohydrochloride, (S)-Isomer

TOPOTECAN, HYCAMTIN

Topotecane

Topotecane [INN-French]

Topotecanum

Topotecanum [INN-Latin]

TPT

TTC

UNII-7M7YKX2N15

Iodine

Approved, Investigational

Phase 2

7553-56-2

807

Paclitaxel

Approved, Vet_approved

Phase 2

33069-62-4

36314

Synonyms:

(2AR-(2aalpha,4b,4abeta,6b,9a(a r*,betas*),11a,12a,12balpha))-b-(benzoylamino)-a-hydroxybenzenepropanoate 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester

(2AR-(2aalpha,4b,4abeta,6b,9a(a r*,betas*),11a,12a,12balpha))-b-(benzoylamino)-a-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester

(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoate 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester

(2AR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha r*,betas*),11alpha,12alpha,12balpha))-beta-(benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester

(2AR-(2aalpha,4β,4abeta,6β,9α(α r*,betas*),11α,12α,12balpha))-β-(benzoylamino)-α-hydroxybenzenepropanoate 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester

(2AR-(2aalpha,4β,4abeta,6β,9α(α r*,betas*),11α,12α,12balpha))-β-(benzoylamino)-α-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester

12-benzoate, 9-ester with (2R,3S)-N-benzoyl-3-phenylisoserine

157069-30-2

33069-62-4

5b,20-Epoxy-1,2-a,4,7b,10b,13a-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine

5b,20-Epoxy-1,2-a,4,7b,10b,13a-hexahydroxytax-11-en-9-one 4,10-diacetic acid 2-benzoic acid 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine

5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine

5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetic acid 2-benzoic acid 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine

5β,20-epoxy-1,2-α,4,7β,10β,13α-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine

5β,20-epoxy-1,2-α,4,7β,10β,13α-hexahydroxytax-11-en-9-one 4,10-diacetic acid 2-benzoic acid 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine

7 Epi taxol

7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxete, benzenepropanoic acid deriv.

7,11-Methano-5H-cyclodeca[3,4]benz[1,2-b]oxete,benzenepropanoic acid deriv.

7-epi-Paclitaxel

7-Epipaclitaxel

7-Epi-paclitaxel

7-epi-Taxol

7-Epitaxol

7-Epi-taxol

AB00513812

ABI 007

abi-007

ABI007

ABI-007

Abraxane

Abraxane (TN)

Abraxane I.V. Suspension

Abraxis BioScience brand of albumin-bound paclitaxel

AC1L1IOG

AC1L1VJI

AC1L9AVF

AC-675

ACon1_002231

albumin-bound paclitaxel

Ambotz33069-62-4

ANX-513

Anzatax

Asotax

BIDD:PXR0046

Bio-0076

Bio1_000362

Bio1_000851

Bio1_001340

Bio2_000416

Bio2_000896

BMS 181339-01

BMS-181339

BMS-181339-01

BPBio1_000320

BRD-A23723433-001-01-2

BRD-A28746609-001-04-0

BRD-K62008436-001-03-1

Bris taxol

Bristaxol

BSPBio_000290

BSPBio_001152

BSPBio_002614

C07394

C466458

C47H51NO14

Capxol

CCRIS 8143

CHEBI:103439

CHEBI:45863

CHEMBL100910

CHEMBL418410

CHEMBL48

CID36314

CID441276

CID4666

CID6713921

CID6915727

cMAP_000068

CPD-8718

D00491

DB01229

DHP-107

DHP-208

DivK1c_000441

DRG-0190

DTS-301

Ebetaxel

EmPAC

Epitaxol

EU-0101201

Genaxol

Genetaxyl

Genexol

Genexol-PM

HMS1362J13

HMS1568O12

HMS1792J13

HMS1922K08

HMS1990J13

HMS2090D07

HMS2093K15

HMS501G03

HSDB 6839

I06-0014

IDI1_000441

IDI1_002171

Intaxel

KBio1_000441

KBio2_000492

KBio2_002016

KBio2_002509

KBio2_003060

KBio2_004584

KBio2_005077

KBio2_005628

KBio2_007152

KBio2_007645

KBio3_000903

KBio3_000904

KBio3_001834

KBio3_002987

KBioGR_000492

KBioGR_001893

KBioGR_002509

KBioSS_000492

KBioSS_002016

KBioSS_002517

LipoPac

LMPR0104390001

Lopac0_001201

LS-31070

MBT 0206

MEGxp0_001940

Micellar Paclitaxel

Mitotax

MLS000863266

MLS001077297

MLS002154218

MLS002172439

MLS002695976

MolPort-001-742-627

MolPort-003-665-783

MolPort-003-932-365

MPI-5018

nab-paclitaxel

Nanotaxel

NCGC00024995-02

NCGC00024995-03

NCGC00024995-04

NCGC00024995-05

NCGC00024995-06

NCGC00024995-07

NCGC00164367-01

NCGC00164367-02

NCGC00164367-03

nchembio.188-comp1

nchembio.2007.34-comp9

nchembio.215-comp9

nchembio853-comp6

NCI60_000601

Neuro_000060

NINDS_000441

NK 105

Nova-12005

NP-010981

NSC 125973

NSC125973

NSC-125973

NSC358882

OAS-PAC-100

OncoGel

Onxal

Onxol

Onxol, Taxol, Nov-Onxol, Paclitaxel

P1632

Paclical

Pacligel

paclitaxel

Paclitaxel

Paclitaxel (JAN/USP)

Paclitaxel (JAN/USP/INN)

Paclitaxel (Taxol)

Paclitaxel [USAN:INN:BAN]

Paclitaxel, (4 alpha)-isomer

Paxceed

Paxene

Paxoral

Plaxicel

Praxel

Prestwick0_000155

Prestwick1_000155

Prestwick2_000155

Prestwick3_000155

Probes2_000350

QW 8184

S1150_Selleck

S-8184 Paclitaxel Injectable Emulsion

SDCCGMLS-0066823.P001

SDP-013

SMP1_000228

SMR000394086

SMR000857385

SPBio_000943

SPBio_002229

Spectrum_001536

SPECTRUM1503908

Spectrum2_000872

Spectrum3_001057

Spectrum4_001197

Spectrum5_001491

ST50306996

T 7402

T1912_SIGMA

T7191_SIGMA

T7402_SIGMA

TA1

TaxAlbin

Taxol

TAXOL

TAXOL (TN)

Taxol a

Taxol A

Taxol Konzentrat

TAXOL, 10-EPI,

Taxol, bris

Taxol.RTM. (Registered Trademark)

TXL

UNII-P88XT4IS4D

UPCMLD-DP108:001

UPCMLD-DP108:002

Vascular Wrap

weekly paclitaxel

Xorane

Yewtaxan

Acetylcysteine

Approved, Investigational

Phase 2

616-91-1

12035

Synonyms:

(2R)-2-acetylamino-3-Sulfanylpropanoate

(2R)-2-acetylamino-3-sulfanylpropanoic acid

(2R)-2-acetylamino-3-Sulfanylpropanoic acid

(2R)-2-acetylamino-3-Sulphanylpropanoate

(2R)-2-acetylamino-3-Sulphanylpropanoic acid

(R)-2-acetylamino-3-Mercaptopropanoate

(R)-2-acetylamino-3-mercaptopropanoic acid

(R)-2-acetylamino-3-Mercaptopropanoic acid

(R)-Mercaptate

(R)-Mercaptic acid

(R)-mercapturic acid

(R)-Mercapturic acid

2-acetylamino-3-mercapto-Propionate

2-acetylamino-3-mercapto-Propionic acid

Ac pharma brand OF acetylcysteine

ACC

Acebraus

Acemuc

Acetabs

Acetadote

Acetilcisteina

Acetylcystein al

Acetylcystein atid

Acetylcystein heumann

Acetylcystein trom

Acetylcystein, mentopin

Acetylcysteine ac-pharma brand

Acetylcysteine alcon brand

Acetylcysteine aluid brand

Acetylcysteine atid brand

Acetylcysteine azupharma brand

Acetylcysteine betapharm brand

Acetylcysteine bioiberica brand

Acetylcysteine bouchara brand

Acetylcysteine centrafarm brand

Acetylcysteine disphar brand

Acetylcysteine farmasan brand

Acetylcysteine fresenius brand

Acetylcysteine génévrier brand

Acétylcystéine GNR

Acetylcysteine GNR-pharma brand

Acetylcysteine guerbet brand

Acetylcysteine hermes brand

Acetylcysteine heumann brand

Acetylcysteine hydrochloride

Acetylcysteine inpharzam brand

Acetylcysteine intra brand

Acetylcysteine klinge brand

Acetylcysteine krewel brand

Acetylcysteine lichtenstein brand

Acetylcysteine lindopharm brand

Acetylcysteine merck brand

Acetylcysteine oberlin brand

Acetylcysteine pfleger brand

Acetylcysteine pharbita brand

Acetylcysteine roberts brand

Acetylcysteine sodium

Acetylcysteine temmler brand

Acetylcysteine teva brand

Acetylcysteine thiemann brand

Acetylcysteine trommsdorff brand

Acetylcysteine upsa brand

Acetylcysteine whitehall brand

Acetylcysteine zambon brand

Acetylcysteine zinc

Acetylcysteine zyma brand

Acetylcysteine, (D)-isomer

Acetylcysteine, (DL)-isomer

Acetylcysteine, monoammonium salt

Acetylcysteine, monosodium salt

Acetylcysteinum

Acetylin

Acetyst

Acid, mercapturic

Ac-pharma brand OF acetylcysteine

Airbron

Alcon brand OF acetylcysteine

Allen and hanburys brand OF acetylcysteine

Aluid brand OF acetylcysteine

Alveolex

Atid brand OF acetylcysteine

Azubronchin

Azupharma brand OF acetylcysteine

Betapharm brand OF acetylcysteine

Bioiberica brand OF acetylcysteine

Bisolvon nac

Boehringer ingelheim brand OF acetylcysteine

Bouchara brand OF acetylcysteine

Bristol myers squibb brand OF acetylcysteine

Bristol myers squibb brand OF acetylcysteine sodium salt

Bristol-myers squibb brand OF acetylcysteine

Bristol-myers squibb brand OF acetylcysteine sodium salt

Bromuc

broncho Fips

broncho-Fips

BronchoFips

Broncholysin

Broncoclar

Centrafarm brand OF acetylcysteine

Codotussyl

Cystamucil

dampo Mucopect

Dey brand OF acetylcysteine sodium salt

Disphar brand OF acetylcysteine

Durabronchal

Eurespiran

Exomuc

Fabrol

Farmasan brand OF acetylcysteine

Fluimicil infantil

Fluimucetin

Fluimucil

Flumucetin

Fluprowit

Frekatuss

Fresenius brand OF acetylcysteine

Genac

Génévrier brand OF acetylcysteine

GNR Pharma brand OF acetylcysteine

GNR-Pharma brand OF acetylcysteine

Guerbet brand OF acetylcysteine

Hermes brand OF acetylcysteine

Heumann brand OF acetylcysteine

Hoestil

Hustengetränk, optipect

Hydrochloride, acetylcysteine

Ilube

Inpharzam brand OF acetylcysteine

Intra brand OF acetylcysteine

Jenacystein

Jenapharm

Klinge brand OF acetylcysteine

Krewel brand OF acetylcysteine

L-a-acetamido-b-Mercaptopropionate

L-a-acetamido-b-Mercaptopropionic acid

L-acetylcysteine

L-Acetylcysteine

L-alpha-acetamido-beta-Mercaptopropionate

L-alpha-acetamido-beta-Mercaptopropionic acid

Lantamed

Larylin nac

Lichtenstein brand OF acetylcysteine

Lindocetyl

Lindopharm brand OF acetylcysteine

Lysox

L-α-acetamido-β-mercaptopropionate

L-α-acetamido-β-mercaptopropionic acid

m Pectil

Mentopin acetylcystein

Mercaptate

Mercaptic acid

Mercapturic acid

Merck brand OF acetylcysteine

Monoammonium salt acetylcysteine

Monosodium salt acetylcysteine

m-Pectil

MPectil

Muciteran

muco Sanigen

Mucolysin

Mucomyst

Mucopect, dampo

Mucosil

Mucosol

Mucosolvin

N Acetyl L cysteine

N Acetylcysteine

NAC

NAC al

NAC zambon

NAC, bisolvon

N-Acetyl-3-mercaptoalanine

N-acetylcysteine

N-Acetylcysteine

N-Acety-L-cysteine

N-acetyl-L-(+)-cysteine

N-Acetyl-L-(+)-cysteine

N-acetyl-L-cysteine

Oberlin brand OF acetylcysteine

Optipect hustengetränk

Parvolex

Pfleger brand OF acetylcysteine

Pharbita brand OF acetylcysteine

Produpharm lappe brand OF acetylcysteine

Roberts brand OF acetylcysteine

Roche nicholas brand OF acetylcysteine

Sanigen, muco

Siccoral

Siran

Sodium 2-acetamido-3-mercaptopropionate

Sodium, acetylcysteine

Solmucol

Temmler brand OF acetylcysteine

Teva brand OF acetylcysteine

Thiemann brand OF acetylcysteine

Trommsdorff brand OF acetylcysteine

UPSA brand OF acetylcysteine

Whitehall brand OF acetylcysteine

Zambon brand OF acetylcysteine

Zambon, nac

Zinc, acetylcysteine

Zyma brand OF acetylcysteine

Doxil

Approved June 1999

Phase 2

31703

topoisomerase I inhibitors

Phase 2

Albumin-Bound Paclitaxel

Phase 2

Topoisomerase Inhibitors

Phase 2

Anti-Bacterial Agents

Phase 2

Antibiotics, Antitubercular

Phase 2

Immunosuppressive Agents

Phase 2,Phase 1

Anti-Infective Agents

Phase 2,Phase 1

Antimetabolites

Phase 2

Antiviral Agents

Phase 2,Phase 1

Antimetabolites, Antineoplastic

Phase 2

Antimitotic Agents

Phase 2

Antineoplastic Agents, Phytogenic

Phase 2

Respiratory System Agents

Phase 2

N-monoacetylcystine

Phase 2

Expectorants

Phase 2

Antidotes

Phase 2

Antioxidants

Phase 2

Protective Agents

Phase 2

cysteine

Nutraceutical

Phase 2

CHI3L1 protein, human

Interventional clinical trials:

#	Name	Status	NCT ID	Phase	Drugs
1	MV-NIS or Investigator's Choice Chemotherapy in Treating Patients With Ovarian, Fallopian, or Peritoneal Cancer	Recruiting	NCT02364713	Phase 2	Gemcitabine Hydrochloride;Paclitaxel;Pegylated Liposomal Doxorubicin Hydrochloride;Topotecan Hydrochloride
2	Effect of Acetylcysteine With Topotecan Hydrochloride on the Tumor Microenvironment in Patients With Persistent or Recurrent High Grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer	Terminated	NCT02569957	Phase 2	Topotecan Hydrochloride;Topotecan Hydrochloride;Acetylcysteine
3	Activated T-cell Therapy, Low-Dose Aldesleukin, and Sargramostim in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer That is Stage III-IV, Refractory, or Recurrent	Withdrawn	NCT02470559	Phase 1
4	YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Receiving Chemotherapy	Terminated	NCT00899093

Search NIH Clinical Center for Ovary Serous Adenocarcinoma

Sources

Genetic Tests for Ovary Serous Adenocarcinoma

Sources

Anatomical Context for Ovary Serous Adenocarcinoma

MalaCards organs/tissues related to Ovary Serous Adenocarcinoma:

⁴¹

Ovary, T Cells

Sources

Publications for Ovary Serous Adenocarcinoma

Articles related to Ovary Serous Adenocarcinoma:

#	Title	Authors	Year
1	Invasion patterns of metastatic high-grade serous carcinoma of ovary or fallopian tube associated with BRCA deficiency. ( 24577588 )	Reyes M.C....Soslow R.A.	2014
2	Synchronous occurrence of endometrial stromal nodule with papillary serous carcinoma of ovary: report of a case and brief review of literature. ( 25404842 )	Mitra S....Mukhopadhyay S.	2014
3	Loss of expression of EphB1 protein in serous carcinoma of ovary associated with metastasis and poor survival. ( 24427352 )	Wang H....Wang J.	2014
4	Choriocarcinoma arising in a serous carcinoma of ovary: an example of histopathology driving treatment. ( 20707961 )	Hafezi-Bakhtiari S....Colgan T.J.	2010
5	MicroRNA profiling of BRCA1/2 mutation-carrying and non-mutation-carrying high-grade serous carcinomas of ovary. ( 19798417 )	Lee C.H....Gilks C.B.	2009

Sources

Genes for Ovary Serous Adenocarcinoma

Genes related to Ovary Serous Adenocarcinoma (0 elite genes):

(show all 12)

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Evidence
1	HTRA3	HtrA Serine Peptidase 3	Protein Coding	15.41	DISEASES inferred ¹⁵ GeneCards inferred via : DISEASES inferred (show sections)
2	KRAS	KRAS Proto-Oncogene, GTPase	Protein Coding	15.15	DISEASES inferred ¹⁵ GeneCards inferred via : DISEASES inferred (show sections)
3	UBE4A	Ubiquitination Factor E4A	Protein Coding	15.03	DISEASES inferred ¹⁵ GeneCards inferred via : DISEASES inferred (show sections)
4	ZNF217	Zinc Finger Protein 217	Protein Coding	14.94	DISEASES inferred ¹⁵ GeneCards inferred via : DISEASES inferred (show sections)
5	HRAS	HRas Proto-Oncogene, GTPase	Protein Coding	14.89	DISEASES inferred ¹⁵ GeneCards inferred via : DISEASES inferred (show sections)
6	GNAS	GNAS Complex Locus	Protein Coding	14.77	DISEASES inferred ¹⁵ GeneCards inferred via : DISEASES inferred (show sections)
7	PNPT1	Polyribonucleotide Nucleotidyltransferase 1	Protein Coding	14.73	DISEASES inferred ¹⁵ GeneCards inferred via : DISEASES inferred (show sections)
8	RPA3	Replication Protein A3	Protein Coding	14.67	DISEASES inferred ¹⁵ GeneCards inferred via : DISEASES inferred (show sections)
9	USP2	Ubiquitin Specific Peptidase 2	Protein Coding	14.65	DISEASES inferred ¹⁵ GeneCards inferred via : DISEASES inferred (show sections)
10	CLEC4C	C-Type Lectin Domain Family 4 Member C	Protein Coding	14.64	DISEASES inferred ¹⁵ GeneCards inferred via : DISEASES inferred (show sections)
11	NBEAL1	Neurobeachin Like 1	Protein Coding	7.5	GeneCards inferred via : Expressions (show sections)
12	CEACAM5	Carcinoembryonic Antigen Related Cell Adhesion Molecule 5	Protein Coding	6.35	DISEASES inferred ¹⁵

Sources

Variations for Ovary Serous Adenocarcinoma

Cosmic variations for Ovary Serous Adenocarcinoma:

⁹

(show top 50) (show all 1230)

#	Cosmic Mut ID	Gene Symbol	COSMIC Disease Classification (Primary site, Site subtype, Primary histology, Histology subtype)	Mutation CDS	Mutation AA	GRCh38 Location	Conf
1	COSM10663	TP53	ovary,NS,carcinoma,adenocarcinoma	c.916C>T	p.R306*	17:7673704-7673704	8
2	COSM11066	TP53	ovary,NS,carcinoma,adenocarcinoma	c.578A>T	p.H193L	17:7674953-7674953	8
3	COSM10738	TP53	ovary,NS,carcinoma,adenocarcinoma	c.542G>A	p.R181H	17:7675070-7675070	8
4	COSM11148	TP53	ovary,NS,carcinoma,adenocarcinoma	c.476C>T	p.A159V	17:7675136-7675136	8
5	COSM6904336	TNFAIP3	ovary,NS,carcinoma,adenocarcinoma	c.940G>A	p.V314I	6:137877210-137877210	8
6	COSM14135	SMAD4	ovary,NS,carcinoma,adenocarcinoma	c.1051G>C	p.D351H	18:51065518-51065518	8
7	COSM6904335	SMAD2	ovary,NS,carcinoma,adenocarcinoma	c.785-1G>C	p.?	18:47848688-47848688	8
8	COSM6904334	RET	ovary,NS,carcinoma,adenocarcinoma	c.3253A>G	p.T1085A	10:43128177-43128177	8
9	COSM6904339	PTCH1	ovary,NS,carcinoma,adenocarcinoma	c.3074G>A	p.R1025H	9:95458107-95458107	8
10	COSM770	PIK3CA	ovary,NS,carcinoma,adenocarcinoma	c.2725T>C	p.F909L	3:179230062-179230062	8
11	COSM21446	PIK3CA	ovary,NS,carcinoma,adenocarcinoma	c.3012G>T	p.M1004I	3:179234169-179234169	8
12	COSM746	PIK3CA	ovary,NS,carcinoma,adenocarcinoma	c.263G>A	p.R88Q	3:179199088-179199088	8
13	COSM94978	PIK3CA	ovary,NS,carcinoma,adenocarcinoma	c.1034A>T	p.N345I	3:179203764-179203764	8
14	COSM766	PIK3CA	ovary,NS,carcinoma,adenocarcinoma	c.1636C>A	p.Q546K	3:179218306-179218306	8
15	COSM580	NRAS	ovary,NS,carcinoma,adenocarcinoma	c.181C>A	p.Q61K	1:114713909-114713909	8
16	COSM564	NRAS	ovary,NS,carcinoma,adenocarcinoma	c.35G>A	p.G12D	1:114716126-114716126	8
17	COSM14065	ERBB2	ovary,NS,carcinoma,adenocarcinoma	c.2524G>A	p.V842I	17:39725079-39725079	8
18	COSM22992	EGFR	ovary,NS,carcinoma,adenocarcinoma	c.2161G>A	p.G721S	7:55174020-55174020	8
19	COSM53264	EGFR	ovary,NS,carcinoma,adenocarcinoma	c.2174C>T	p.T725M	7:55174033-55174033	8
20	COSM53230	EGFR	ovary,NS,carcinoma,adenocarcinoma	c.2597A>G	p.E866G	7:55191846-55191846	8
21	COSM28511	EGFR	ovary,NS,carcinoma,adenocarcinoma	c.2108T>C	p.L703P	7:55173967-55173967	8
22	COSM53225	EGFR	ovary,NS,carcinoma,adenocarcinoma	c.2112G>A	p.L704L	7:55173971-55173971	8
23	COSM53232	EGFR	ovary,NS,carcinoma,adenocarcinoma	c.2122A>G	p.K708E	7:55173981-55173981	8
24	COSM53266	EGFR	ovary,NS,carcinoma,adenocarcinoma	c.2165C>T	p.A722V	7:55174024-55174024	8
25	COSM53224	EGFR	ovary,NS,carcinoma,adenocarcinoma	c.2173A>G	p.T725A	7:55174032-55174032	8
26	COSM53213	EGFR	ovary,NS,carcinoma,adenocarcinoma	c.2604A>T	p.E868D	7:55191853-55191853	8
27	COSM53229	EGFR	ovary,NS,carcinoma,adenocarcinoma	c.2232C>A	p.I744I	7:55174769-55174769	8
28	COSM53231	EGFR	ovary,NS,carcinoma,adenocarcinoma	c.2559C>T	p.I853I	7:55191808-55191808	8
29	COSM12373	EGFR	ovary,NS,carcinoma,adenocarcinoma	c.2159C>T	p.S720F	7:55174018-55174018	8
30	COSM53265	EGFR	ovary,NS,carcinoma,adenocarcinoma	c.2556G>T	p.K852N	7:55191805-55191805	8
31	COSM53235	EGFR	ovary,NS,carcinoma,adenocarcinoma	c.2481C>T	p.Y827Y	7:55191730-55191730	8
32	COSM53226	EGFR	ovary,NS,carcinoma,adenocarcinoma	c.2099A>G	p.N700S	7:55173958-55173958	8
33	COSM28286	EGFR	ovary,NS,carcinoma,adenocarcinoma	c.2494C>T	p.R832C	7:55191743-55191743	8
34	COSM53228	EGFR	ovary,NS,carcinoma,adenocarcinoma	c.2123A>G	p.K708R	7:55173982-55173982	8
35	COSM53227	EGFR	ovary,NS,carcinoma,adenocarcinoma	c.2506C>A	p.R836S	7:55191755-55191755	8
36	COSM6224	EGFR	ovary,NS,carcinoma,adenocarcinoma	c.2573T>G	p.L858R	7:55191822-55191822	8
37	COSM22499	ATM	ovary,NS,carcinoma,adenocarcinoma	c.1810C>T	p.P604S	11:108252824-108252824	8
38	COSM6904304	AR	ovary,NS,carcinoma,adenocarcinoma	c.2179C>T	p.R727C	23:67717483-67717483	8
39	COSM159008	AKT1	ovary,NS,carcinoma,adenocarcinoma	c.235C>A	p.Q79K	14:104776711-104776711	8
40	COSM6906506	ZFHX3	ovary,NS,carcinoma,serous carcinoma	c.794A>C	p.D265A	16:72959352-72959352	6
41	COSM6914646	YES1	ovary,NS,carcinoma,serous carcinoma	c.194C>T	p.S65F	18:756634-756634	6
42	COSM6969549	XRCC2	ovary,NS,carcinoma,serous carcinoma	c.121G>C	p.G41R	7:152660701-152660701	6
43	COSM6910241	XPO1	ovary,NS,carcinoma,serous carcinoma	c.1072T>C	p.S358P	2:61494067-61494067	6
44	COSM3446768	WT1	ovary,NS,carcinoma,serous carcinoma	c.1285G>A	p.D429N	11:32389123-32389123	6
45	COSM20660	WNK2	ovary,NS,carcinoma,serous carcinoma	c.1486G>T	p.V496L	9:93239962-93239962	6
46	COSM20717	WNK1	ovary,NS,carcinoma,serous carcinoma	c.2829C>T	p.Y943Y	12:880028-880028	6
47	COSM1035874	VHL	ovary,NS,carcinoma,serous carcinoma	c.430G>A	p.G144R	3:10146603-10146603	6
48	COSM6923147	TSC2	ovary,NS,carcinoma,serous carcinoma	c.4998C>A	p.F1666L	16:2087871-2087871	6
49	COSM6975218	TSC2	ovary,NS,carcinoma,serous carcinoma	c.1361+1G>A	p.?	16:2062601-2062601	6
50	COSM6908724	TSC2	ovary,NS,carcinoma,serous carcinoma	c.1217G>A	p.R406K	16:2061968-2061968	6

Sources

Expression for Ovary Serous Adenocarcinoma

Search GEO for disease gene expression data for Ovary Serous Adenocarcinoma.

Sources

Pathways for Ovary Serous Adenocarcinoma

Pathways related to Ovary Serous Adenocarcinoma according to GeneCards Suite gene sharing:

(show all 16)

#	Super pathways	Score	Top Affiliating Genes
1	Cell surface interactions at the vascular wall ⁶⁶ Show member pathways Fibronectin matrix formation ⁶⁶ PECAM1 interactions ⁶⁶ Tie2 Signaling ⁶⁶	11.94	CEACAM5 HRAS KRAS
2	C-type lectin receptor signaling pathway ³⁷ Show member pathways Pathogen or Damage-activated C-Type Lectin Receptor Signaling Pathways ⁶⁵	11.89	CLEC4C HRAS KRAS
3	Long-term potentiation ³⁷ Show member pathways Common Pathways Underlying Drug Addiction ¹ Dopamine D1-Like Receptor Family Signaling Pathways ⁶⁵	11.85	GNAS HRAS KRAS
4	Development EGFR signaling via small GTPases ²² Show member pathways Development EGFR signaling via PIP3 ²² Development PDGF signaling via MAPK cascades ²² PDGF Pathway ¹	11.72	GNAS HRAS KRAS
5	Serotonergic synapse ³⁷	11.49	GNAS HRAS KRAS
6	BDNF-TrkB Signaling ¹	11.09	HRAS KRAS
7	Gap junction ³⁷	11.08	GNAS HRAS KRAS
8	Extracellular vesicle-mediated signaling in recipient cells ¹	11.02	HRAS KRAS
9	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities ¹	11.01	HRAS KRAS
10	Bisphosphonate Pathway, Pharmacodynamics ⁶¹ Show member pathways RalA downstream regulated genes ¹	10.99	HRAS KRAS
11	EGFR Transactivation by Gastrin ⁶⁶ Show member pathways EGFR-dependent Endothelin signaling events ¹ SHC-related events triggered by IGF1R ⁶⁶	10.91	HRAS KRAS
12	MNAR-PELP1 and Estrogen Receptor Interaction ⁶⁴	10.79	HRAS KRAS
13	CD209 (DC-SIGN) signaling ⁶⁶	10.75	HRAS KRAS
14	Serotonin Receptor 2 and ELK-SRF/GATA4 signaling ¹	10.62	HRAS KRAS
15	Long-term depression ³⁷	10.58	GNAS HRAS KRAS
16	p38MAPK events ⁶⁶	10.27	HRAS KRAS

Sources

GO Terms for Ovary Serous Adenocarcinoma

Biological processes related to Ovary Serous Adenocarcinoma according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	leukocyte migration	GO:0050900	9.43	CEACAM5 HRAS KRAS
2	regulation of long-term neuronal synaptic plasticity	GO:0048169	9.16	HRAS KRAS
3	stimulatory C-type lectin receptor signaling pathway	GO:0002223	9.13	CLEC4C HRAS KRAS
4	response to isolation stress	GO:0035900	8.62	HRAS KRAS

Sources

Sources for Ovary Serous Adenocarcinoma

¹ BioSystems

² BitterDB

³ CDC

⁴ Cell Signaling Technology

⁵ ClinicalTrials

⁶ ClinVar

⁷ CNVD

⁸ Cochrane Library

⁹ Cosmic

¹⁰ dbSNP

¹¹ DGIdb

¹² Disease Ontology

¹³ diseasecard

¹⁴ DiseaseEnhancer

¹⁵ DISEASES

¹⁶ DrugBank

¹⁷ ExPASy

¹⁸ FDA Approved Drugs

¹⁹ FMA

²⁰ GeneAnalytics

²¹ GeneCards

²² GeneGo (Thomson Reuters)

²³ GeneHancer via GeneCards

²⁴ GeneReviews

²⁵ Genetics Home Reference

²⁶ GenomeRNAi

²⁷ GEO DataSets

²⁸ GO

²⁹ GTR

³⁰ HGMD

³¹ HMDB

³² HPO

³³ ICD10

³⁴ ICD10 via Orphanet

³⁵ ICD9CM

³⁶ IUPHAR

³⁷ KEGG

³⁸ LifeMap

³⁹ LncRNADisease

⁴⁰ LOVD

⁴¹ MalaCards

⁴² MedGen

⁴³ MedlinePlus

⁴⁴ MeSH

⁴⁵ MESH via Orphanet

⁴⁶ MGI

⁴⁷ miR2Disease

⁴⁸ NCBI Bookshelf

⁴⁹ NCI

⁵⁰ NCIt

⁵¹ NDF-RT

⁵² NIH Clinical Center

⁵³ NIH Rare Diseases

⁵⁴ NINDS

⁵⁵ Novoseek

⁵⁶ Novus Biologicals

⁵⁷ OMIM

⁵⁸ OMIM via Orphanet

⁵⁹ Orphanet

⁶⁰ PathCards

⁶¹ PharmGKB

⁶² PubMed

⁶³ PubMed Health

⁶⁴ QIAGEN

⁶⁵ R&D Systems

⁶⁶ Reactome

⁶⁷ Sino Biological

⁶⁸ SNOMED-CT

⁶⁹ SNOMED-CT via HPO

⁷⁰ SNOMED-CT via Orphanet

⁷¹ TGDB

⁷² Tocris

⁷³ UMLS

⁷⁴ UMLS via Orphanet

⁷⁵ UniProtKB/Swiss-Prot

⁷⁶ Wikipedia